Skip to Main Content

Advertisement

Skip Nav Destination

P4-09-27: Can We Predict the Benefit of the 70-Gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors in Daily Practice? A Single Institution Experience.

Cancer Res (2011) 71 (24_Supplement): P4-09-27.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Sue Harnan
  • Paul Tappenden
  • Katy Cooper
  • John Stevens
  • Alice Bessey
  • Rachid Rafia
  • Sue Ward
  • Ruth Wong
  • Robert C Stein
  • Janet Brown
Health Technology Assessment (2019) 23 (30): 1.
Close Modal

or Create an Account

Close Modal
Close Modal